Levanase from Bacillus subtilis hydrolyses β-2,6 fructosyl bonds in bacterial levans and in grass fructans

International Journal of Biological Macromolecules
Susanne L JensenTom H Nielsen

Abstract

A Levanase, LevB, from Bacillus subtilis 168, was expressed as a His6-tagged protein in Escherichia coli. The enzyme was purified and characterised for its activity and substrate specificity. LevB has a pH optimum of 6.0-6.5 and a maximum observed specific activity of 3 U mg(-1) using levan from Erwinia herbicola as substrate. Hydrolysis products were analysed by HPAEC, TLC, and NMR using chicory root inulin, mixed linkage fructans purified from ryegrass (Lolium perenne) and levan from E. herbicola as substrates. This revealed that LevB is an endolevanase that selectively cleaves the (β-2,6) fructosyl bonds and does not hydrolyse inulin. Ryegrass fructans and bacterial levan was hydrolysed partially releasing oligosaccharides, but together with exoinulinase, LevB hydrolysed both ryegrass fructans and bacterial levan to near completion. We suggest that LevB can be used as a tool to achieve more structural information on complex fructans and to achieve complete degradation and quantification of mixed linkage fructans.

References

May 16, 2003·Carbohydrate Research·Xiao-Ming Chen, Geng-Yuan Tian
Jul 8, 2008·Journal of Experimental Botany·Ravi Valluru, Wim Van den Ende
Nov 28, 2008·Journal of Experimental Botany·Wim Van den Ende, Ravi Valluru
Mar 18, 2009·Cellular and Molecular Life Sciences : CMLS·David P LivingstonArnd G Heyer
Feb 14, 2012·Journal of Agricultural and Food Chemistry·Joran VerspreetChristophe M Courtin
May 16, 2014·Analytical and Bioanalytical Chemistry·Joran VerspreetScott J Harrison
Jun 2, 2015·Frontiers in Plant Science·Shamila W AbeynayakeBirte Boelt

❮ Previous
Next ❯

Citations

Apr 18, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Huijing GuoMinrui Guo
Aug 12, 2019·Applied Microbiology and Biotechnology·Wenli ZhangWanmeng Mu
Sep 5, 2020·Antioxidants·Henry Christopher Janse van RensburgWim Van den Ende
Sep 28, 2017·Applied Biochemistry and Biotechnology·Sudhir P SinghAshok Pandey
Aug 25, 2021·International Journal of Biological Macromolecules·Iolanda CorradoCinzia Pezzella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.